Published in
Taylor and Francis Group, Journal of Medical Economics (JME), 1(26), p. 1145-1154, 2023
DOI: 10.1080/13696998.2023.2248839
Links
Tools
Cost-effectiveness of apixaban and rivaroxaban in thromboprophylaxis of cancer patients treated with chemotherapy in Spain
Journal article published in 2023 by
Andrés J. Muñoz 
,
Laura Ortega ,
Ana Gutiérrez ,
Enrique Gallardo ,
Darío Rubio-Rodríguez,
Carlos Rubio-Terrés,
Blanca Morón ,
Pilar García-Alfonso ,
José Manuel Soria
,
Laura Ortega ,
Ana Gutiérrez ,
Enrique Gallardo ,
Darío Rubio-Rodríguez,
Carlos Rubio-Terrés,
Blanca Morón ,
Pilar García-Alfonso ,
José Manuel Soria
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 